| J0897 | Injection, denosumab, 1 mg | 25,200 | $20 | $453.6K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 9,300 | $30 | $316.2K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 38,010 | $10 | $304.1K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 72,000 | $1 | $288K |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 16,800 | $20 | $285.6K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 1,060 | $60 | $62.7K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,260 | $30 | $58.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 300 | $110 | $31.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 200 | $100 | $19.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 240 | $70 | $16.2K |